Dr. Dietrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Yawkey Center 9e Pappas Center For Neurooncology
Boston, MA 02114Phone+1 617-724-8770Fax+1 617-724-8769
Education & Training
Rochester General HospitalResidency, Internal Medicine, 2004 - 2005- University of Giessen Faculty of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2008 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) Start of enrollment: 2009 Jan 01
- Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 20 citationsNeurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells.Philipp Karschnia, Kevin C Miller, Andrew J Yee, Kai Rejeski, P Connor Johnson
Blood. 2023-10-05 - 43 citationsSuccessful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.Jeremy S. Abramson, Kelly E. Irwin, Matthew J. Frigault, Jorg Dietrich, Brianne McGree
Cancer. 2019-11-01 - 99 citationsChemotherapy, cognitive impairment and hippocampal toxicityJorg Dietrich, Morgan Prust, J. Kaiser
Neuroscience. 2015-11-19
Press Mentions
GliomasMay 17th, 2018
Ketogenic Diet May Affect Glioma OutcomesJuly 12th, 2017
Chemoradiation for Glioblastoma Reduces Brain VolumeSeptember 3rd, 2015- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
